CN Patent

CN104861028A — 新型熊果酸衍生物、其制备方法及其应用

Assigned to Shanghai Viking Biological Medicine & Technology Co Ltd · Expires 2015-08-26 · 11y expired

What this patent protects

本发明涉及一类新型熊果酸衍生物、其制备方法及其应用。该类化合物为熊果酸结构式中3位和28位取代基的修饰物,以熊果酸为原料,通过化学合成的方法制备,其可以用于治疗癌症、糖尿病、艾滋病、乙型肝炎、丙型肝炎。

USPTO Abstract

本发明涉及一类新型熊果酸衍生物、其制备方法及其应用。该类化合物为熊果酸结构式中3位和28位取代基的修饰物,以熊果酸为原料,通过化学合成的方法制备,其可以用于治疗癌症、糖尿病、艾滋病、乙型肝炎、丙型肝炎。

Drugs covered by this patent

Patent Metadata

Patent number
CN104861028A
Jurisdiction
CN
Classification
Expires
2015-08-26
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Viking Biological Medicine & Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.